Device Week, 19 February 2021 – A Mix Of Insulin Pump; Liquid Biopsy; Transcatheter Device News

Citeline Podcasts

English - February 19, 2021 21:43 - 11 minutes - 6.57 MB - ★★★★★ - 24 ratings
Business News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Pink Sheet Podcast: Dsuvia Warning Letter, Refuse-To-File Impact, CDER’s COVID Workload

Next Episode: Scrip’s Five Must-Know Things – 22 February 2021

In this week’s podcast, Medtech Insight's managing editor Marion Webb discusses Guardant Health’s launch of a new liquid biopsy test to detect early-stage colorectal cancer. Deputy editor Reed Miller discusses Canadian-based Neovasc’s recent funding and what it could mean for its Reducer transcatheter technology. UK-based reporter Barnaby Pickering gives an overview of the fast-growing insulin pump market.

Listen to the podcast via the player below:

Guardant Health Launches Liquid Biopsy Test For Detecting Colorectal Cancer Recurrence

Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021

Neovasc Maintains Investor Confidence Despite FDA Struggles; Sells $72M In Stock

For more information on Medtech Insight and to start a free trial, click here:
http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode: